1. Mixing, diluting, or repackaging biological products outside the scope of an approved biologics license application Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2018 Subject(s): Biological ProductsDrug ApprovalDrug PackagingPrescription DrugsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
